
Daniel F. Coughlin
Examiner (ID: 10950, Phone: (571)270-3748 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 638 |
| Issued Applications | 249 |
| Pending Applications | 71 |
| Abandoned Applications | 333 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20377754
[patent_doc_number] => 20250360247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-27
[patent_title] => TREATED OSSEOUS PARTICULATE FLUFF COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 19/296498
[patent_app_country] => US
[patent_app_date] => 2025-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19296498
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/296498 | TREATED OSSEOUS PARTICULATE FLUFF COMPOSITION | Aug 10, 2025 | Pending |
Array
(
[id] => 20547688
[patent_doc_number] => 12558461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-24
[patent_title] => Biologic matrix for a wound site and related methods
[patent_app_type] => utility
[patent_app_number] => 19/272053
[patent_app_country] => US
[patent_app_date] => 2025-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2535
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19272053
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/272053 | Biologic matrix for a wound site and related methods | Jul 16, 2025 | Issued |
Array
(
[id] => 20149305
[patent_doc_number] => 20250249143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-07
[patent_title] => SYNTHETIC BONE GRAFT AND METHOD FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 19/047054
[patent_app_country] => US
[patent_app_date] => 2025-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19047054
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/047054 | SYNTHETIC BONE GRAFT AND METHOD FOR USING SAME | Feb 5, 2025 | Pending |
Array
(
[id] => 20385378
[patent_doc_number] => 12485087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Use of encapsulated cell therapy for treatment of ophthalmic disorders
[patent_app_type] => utility
[patent_app_number] => 18/934892
[patent_app_country] => US
[patent_app_date] => 2024-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 18439
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18934892
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/934892 | Use of encapsulated cell therapy for treatment of ophthalmic disorders | Oct 31, 2024 | Issued |
Array
(
[id] => 19754022
[patent_doc_number] => 20250042587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => TOPICAL FORMULATIONS AND METHODS FOR BIOACTIVE & BIOAVAILABLE NARINGENIN FOR TREATING SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/922183
[patent_app_country] => US
[patent_app_date] => 2024-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18922183
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/922183 | TOPICAL FORMULATIONS AND METHODS FOR BIOACTIVE & BIOAVAILABLE NARINGENIN FOR TREATING SKIN CONDITIONS | Oct 20, 2024 | Pending |
Array
(
[id] => 19744105
[patent_doc_number] => 20250032670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => 3D PRINTED BONE DEFECT REPAIR SCAFFOLD LOADED WITH EXTRACELLULAR MATRIX OF MESENCHYMAL STEM CELLS AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/896954
[patent_app_country] => US
[patent_app_date] => 2024-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 425
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18896954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/896954 | 3D PRINTED BONE DEFECT REPAIR SCAFFOLD LOADED WITH EXTRACELLULAR MATRIX OF MESENCHYMAL STEM CELLS AND PREPARATION METHOD THEREOF | Sep 25, 2024 | Abandoned |
Array
(
[id] => 19656856
[patent_doc_number] => 20240423921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => COATED ENTERIC SOFTGEL CAPSULES
[patent_app_type] => utility
[patent_app_number] => 18/819242
[patent_app_country] => US
[patent_app_date] => 2024-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18819242
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/819242 | COATED ENTERIC SOFTGEL CAPSULES | Aug 28, 2024 | Pending |
Array
(
[id] => 20501765
[patent_doc_number] => 20260031227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-29
[patent_title] => ORTHOBIOLOGIC IMPLEMENTATION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/810822
[patent_app_country] => US
[patent_app_date] => 2024-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18810822
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/810822 | ORTHOBIOLOGIC IMPLEMENTATION SYSTEM | Aug 20, 2024 | Pending |
Array
(
[id] => 19613012
[patent_doc_number] => 20240398692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => MANUFACTURING METHOD OF COFFEE CELL AND ADVENTITIOUS ROOT CULTURE COMPRISING INCREASED BIOACTIVE SUBSTANCES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/680600
[patent_app_country] => US
[patent_app_date] => 2024-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18680600
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/680600 | MANUFACTURING METHOD OF COFFEE CELL AND ADVENTITIOUS ROOT CULTURE COMPRISING INCREASED BIOACTIVE SUBSTANCES AND USE THEREOF | May 30, 2024 | Pending |
Array
(
[id] => 19599372
[patent_doc_number] => 20240390252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => COSMETIC COMPOSITIONS AND RELATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/671679
[patent_app_country] => US
[patent_app_date] => 2024-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18671679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/671679 | COSMETIC COMPOSITIONS AND RELATED METHODS OF USE | May 21, 2024 | Pending |
Array
(
[id] => 20335242
[patent_doc_number] => 20250339362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-06
[patent_title] => SKINCARE SUPPLEMENTS
[patent_app_type] => utility
[patent_app_number] => 18/654896
[patent_app_country] => US
[patent_app_date] => 2024-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/654896 | SKINCARE SUPPLEMENTS | May 2, 2024 | Pending |
Array
(
[id] => 19503886
[patent_doc_number] => 12115284
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-10-15
[patent_title] => Biologic matrix for a wound site and related methods
[patent_app_type] => utility
[patent_app_number] => 18/624746
[patent_app_country] => US
[patent_app_date] => 2024-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7804
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18624746
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/624746 | Biologic matrix for a wound site and related methods | Apr 1, 2024 | Issued |
Array
(
[id] => 19666183
[patent_doc_number] => 12178904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Contact lenses including medicaments and methods of making and using same including stabilizers of labile components such as drugs
[patent_app_type] => utility
[patent_app_number] => 18/606551
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 26395
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606551
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606551 | Contact lenses including medicaments and methods of making and using same including stabilizers of labile components such as drugs | Mar 14, 2024 | Issued |
Array
(
[id] => 19279910
[patent_doc_number] => 20240216382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => PEDIATRIC POWDER FOR ORAL SUSPENSION CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/606678
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606678 | Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof | Mar 14, 2024 | Issued |
Array
(
[id] => 19186191
[patent_doc_number] => 20240165104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => TREATMENT OF DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/418010
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18418010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/418010 | TREATMENT OF DEPRESSION | Jan 18, 2024 | Pending |
Array
(
[id] => 19081986
[patent_doc_number] => 20240108787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => BONE REGENERATION MATERIAL HAVING A COTTON-WOOL LIKE STRUCTURE FORMED OF A PLURALITY OF ELECTROSPUN FIBERS
[patent_app_type] => utility
[patent_app_number] => 18/542059
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18542059
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/542059 | BONE REGENERATION MATERIAL HAVING A COTTON-WOOL LIKE STRUCTURE FORMED OF A PLURALITY OF ELECTROSPUN FIBERS | Dec 14, 2023 | Abandoned |
Array
(
[id] => 19402010
[patent_doc_number] => 20240285521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/527884
[patent_app_country] => US
[patent_app_date] => 2023-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/527884 | Use of encapsulated cell therapy for treatment of ophthalmic disorders | Dec 3, 2023 | Issued |
Array
(
[id] => 19065556
[patent_doc_number] => 20240099982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => CELLULOSE DERIVATIVE FREE CAPSULE FOR HERBAL EXTRACTS
[patent_app_type] => utility
[patent_app_number] => 18/372209
[patent_app_country] => US
[patent_app_date] => 2023-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18372209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/372209 | CELLULOSE DERIVATIVE FREE CAPSULE FOR HERBAL EXTRACTS | Sep 24, 2023 | Pending |
Array
(
[id] => 19447399
[patent_doc_number] => 20240307529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => COMPOSITION FOR IMMUNE TREATMENT OF ALLERGIC DISEASES COMPRISING HOUSE DUST MITE ANTIGENS AND HYALURONIC ACID HYDROGELS AS ACTIVE INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 18/370598
[patent_app_country] => US
[patent_app_date] => 2023-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18370598
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/370598 | COMPOSITION FOR IMMUNE TREATMENT OF ALLERGIC DISEASES COMPRISING HOUSE DUST MITE ANTIGENS AND HYALURONIC ACID HYDROGELS AS ACTIVE INGREDIENTS | Sep 19, 2023 | Pending |
Array
(
[id] => 19875886
[patent_doc_number] => 20250108143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => DOUBLE-CROSSLINKED FIBRIN GEL, RAW MATERIAL COMPOSITION AND KIT THEREOF, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/841788
[patent_app_country] => US
[patent_app_date] => 2023-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18841788
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/841788 | Double-crosslinked fibrin gel, raw material composition and kit thereof, and application thereof | Aug 16, 2023 | Issued |